C

CanSino Biologics
6185

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$10.78B
EV
HK$9.52B
Shares Outstanding
247.04M
Beta
1.35

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$36.02
P/E 2025E
-
P/Revenue 2025E
8.80x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CanSino Biologics Inc.

gainify

C

CanSino Biologics Inc.

6185

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yu, Xuefeng

Employees

1,494

IPO Date

2019-03-28

Headquarters

401-420, Biomedical Park, 4th Floor, 185 South Avenue, TEDA West District, Tianjin 300457, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved